• Please log in or register to access this feature.

Research Article

You have full text access to this OnlineOpen article

Evidence for involvement of GNB1L in autism†‡

  1. Ying-Zhang Chen1,
  2. Mark Matsushita1,
  3. Santhosh Girirajan2,
  4. Mark Lisowski1,
  5. Elizabeth Sun1,
  6. Youngmee Sul1,
  7. Raphael Bernier3,
  8. Annette Estes4,
  9. Geraldine Dawson5,
  10. Nancy Minshew6,
  11. Gerard D. Shellenberg7,
  12. Evan E. Eichler2,8,
  13. Mark J. Rieder2,
  14. Deborah A. Nickerson2,
  15. Debby W. Tsuang3,9,
  16. Ming T. Tsuang10,
  17. Ellen M. Wijsman1,11,
  18. Wendy H. Raskind1,3,9,*,
  19. Zoran Brkanac3,*

Article first published online: 16 NOV 2011

DOI: 10.1002/ajmg.b.32002

Issue

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Volume 159B, Issue 1, pages 61–71, January 2012

Additional Information

How to Cite

Chen, Y.-Z., Matsushita, M., Girirajan, S., Lisowski, M., Sun, E., Sul, Y., Bernier, R., Estes, A., Dawson, G., Minshew, N., Shellenberg, G. D., Eichler, E. E., Rieder, M. J., Nickerson, D. A., Tsuang, D. W., Tsuang, M. T., Wijsman, E. M., Raskind, W. H. and Brkanac, Z. (2012), Evidence for involvement of GNB1L in autism. Am. J. Med. Genet., 159B: 61–71. doi: 10.1002/ajmg.b.32002

Author Information

  1. 1

    Department of Medicine (Medical Genetics), University of Washington, Seattle, Washington

  2. 2

    Department of Genome Sciences, University of Washington, Seattle, Washington

  3. 3

    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington

  4. 4

    Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington

  5. 5

    Department of Psychiatry, University of North Carolina Chapel Hill, Chapel Hill, North Carolina

  6. 6

    Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania

  7. 7

    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

  8. 8

    Howard Hughes Medical Institute, Seattle, Washington

  9. 9

    VISN-20 Mental Illness Research, Education, and Clinical Center, Department of Veteran Affairs, Seattle, Washington

  10. 10

    Department of Psychiatry University of California, San Diego, La Jolla, California

  11. 11

    Department of Biostatistics, University of Washington, Seattle, Washington

*Division of Medical Genetics, Department of Medicine, University of Washington, D218, Box 357720, Seattle, WA 98195-7720.

  1. †

    How to Cite this Article: Chen Y-Z, Matsushita M, Girirajan S, Lisowski M, Sun E, Sul Y, Bernier R, Estes A, Dawson G, Minshew N, Shellenberg GD, Eichler EE, Rieder MJ, Nickerson DA, Tsuang DW, Tsuang MT, Wijsman EM, Raskind WH, Brkanac Z. 2012. Evidence for Involvement of GNB1L in Autism. Am J Med Genet Part B 159B:61–71.

  2. ‡

    Wendy H. Raskind and Zoran Brkanac equally contributed to this work.

Publication History

  1. Issue published online: 16 DEC 2011
  2. Article first published online: 16 NOV 2011
  3. Manuscript Accepted: 21 OCT 2011
  4. Manuscript Received: 27 JUL 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (662K)

REFERENCES

  • Abrahams BS, Geschwind DH. 2008. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9(5): 341–355.
  • Antshel KM, Aneja A, Strunge L, Peebles J, Fremont WP, Stallone K, Abdulsabur N, Higgins AM, Shprintzen RJ, Kates WR. 2007. Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J Autism Dev Disord 37(9): 1776–1786.
  • Antshel KM, Fremont W, Kates WR. 2008. The neurocognitive phenotype in velo-cardio-facial syndrome: A developmental perspective. Dev Disabil Res Rev 14(1): 43–51.
    Direct Link:
  • APA. 1994. Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association.
  • Bakkaloglu B, O'Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, Chawarska K, Klin A, Ercan-Sencicek AG, Stillman AA, et al. 2008. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 82(1): 165–173.
  • Bassett AS, Scherer SW, Brzustowicz LM. 2010. Copy number variations in schizophrenia: Critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167(8): 899–914.
  • Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, Roberts W, Szatmari P, Pinto D, et al. 2010. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42(6): 489–491.
  • Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, et al. 2003. A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112(1 Pt 1): 101–107.
  • Braff DL, Geyer MA, Swerdlow NR. 2001. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156(2–3): 234–258.
  • Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, et al. 2007. The Consortium on the Genetics of Endophenotypes in Schizophrenia: Model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull 33(1): 33–48.
  • Chapman NH, Estes A, Munson J, Bernier R, Webb SJ, Rothstein JH, Minshew NJ, Dawson G, Schellenberg GD, Wijsman EM. 2011. Genome-scan for IQ discrepancy in autism: Evidence for loci on chromosomes 10 and 16. Hum Genet 129(1): 59–70.
  • Cook EH Jr, Scherer SW. 2008. Copy-number variations associated with neuropsychiatric conditions. Nature 455(7215): 919–923.
  • Dawson G, Estes A, Munson J, Schellenberg G, Bernier R, Abbott R. 2007. Quantitative assessment of autism symptom-related traits in probands and parents: Broader Phenotype Autism Symptom Scale. J Autism Dev Disord 37(3): 523–536.
  • Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, et al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39(1): 25–27.
  • Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, Dawson DB, Thorland EC, Lorentz CP, Goldstein JL, McDonald MT, et al. 2003. Microduplication 22q11.2, an emerging syndrome: Clinical, cytogenetic, and molecular analysis of thirteen patients. Am J Hum Genet 73(5): 1027–1040.
  • Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. 2005. PMUT: A web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21(14): 3176–3178.
  • Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS. 2005. Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35(4): 461–470.
  • Funke B, Edelmann L, McCain N, Pandita RK, Ferreira J, Merscher S, Zohouri M, Cannizzaro L, Shanske A, Morrow BE. 1999. Der(22) syndrome and velo-cardio-facial syndrome/DiGeorge syndrome share a 1.5-Mb region of overlap on chromosome 22q11. Am J Hum Genet 64(3): 747–758.
  • Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95(17): 9991–9996.
  • Gong L, Liu M, Jen J, Yeh ET. 2000. GNB1L, a gene deleted in the critical region for DiGeorge syndrome on 22q11, encodes a G-protein beta-subunit-like polypeptide. Biochim Biophys Acta 1494(1–2): 185–188.
  • Goode DL, Cooper GM, Schmutz J, Dickson M, Gonzales E, Tsai M, Karra K, Davydov E, Batzoglou S, Myers RM, et al. 2010. Evolutionary constraint facilitates interpretation of genetic variation in resequenced human genomes. Genome Res 20(3): 301–310.
  • Gothelf D, Eliez S, Thompson T, Hinard C, Penniman L, Feinstein C, Kwon H, Jin S, Jo B, Antonarakis SE, et al. 2005. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8(11): 1500–1502.
  • Highsmith WE Jr, Meyer KJ, Marley VM, Jenkins RB. 2007. Conversion Technology for the separation of maternal and paternal copies of any autosomal chromosome in somatic cell hybrids. Curr Protoc Hum Genet 55: 3.6.1–3.6.38.
  • Horowitz A, Shifman S, Rivlin N, Pisante A, Darvasi A. 2005. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 73(2–3): 263–267.
  • Ishiguro H, Koga M, Horiuchi Y, Noguchi E, Morikawa M, Suzuki Y, Arai M, Niizato K, Iritani S, Itokawa M, et al. 2010. Supportive evidence for reduced expression of GNB1L in schizophrenia. Schizophr Bull 36(4): 756–765.
  • Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34(1): 27–29.
  • Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, et al. 2008. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82(1): 199–207.
  • Korvatska O, Estes A, Munson J, Dawson G, Bekris LM, Kohen R, Yu CE, Schellenberg GD, Raskind WH. 2011. Mutations in the TSGA14 gene in families with autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 156(B): 303–311.
  • Li Y, Zhao Q, Wang T, Liu J, Li J, Li T, Zeng Z, Feng G, He L, Shi Y. 2011. Association study between GNB1L and three major mental disorders in Chinese Han populations. Psychiatry Res 187(3): 457–459.
  • Liao J, Kochilas L, Nowotschin S, Arnold JS, Aggarwal VS, Epstein JA, Brown MC, Adams J, Morrow BE. 2004. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet 13(15): 1577–1585.
  • Lo-Castro A, Galasso C, Cerminara C, El-Malhany N, Benedetti S, Nardone AM, Curatolo P. 2009. Association of syndromic mental retardation and autism with 22q11.2 duplication. Neuropediatrics 40(3): 137–140.
  • Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30(3): 205–223.
  • Lord C, Rutter M, Le Couteur A. 1994. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5): 659–685.
  • McClellan JM, Susser E, King MC. 2007. Schizophrenia: A common disease caused by multiple rare alleles. Br J Psychiatry 190: 194–199.
  • Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, et al. 2007. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81(6): 1289–1297.
  • Moss EM, Batshaw ML, Solot CB, Gerdes M, McDonald-McGinn DM, Driscoll DA, Emanuel BS, Zackai EH, Wang PP. 1999. Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr 134(2): 193–198.
  • Mukaddes NM, Herguner S. 2007. Autistic disorder and 22q11.2 duplication. World J Biol Psychiatry 8(2): 127–130.
  • Murphy KC. 2005. Annotation: Velo-cardio-facial syndrome. J Child Psychol Psychiatry 46(6): 563–571.
    Direct Link:
  • Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56(10): 940–945.
  • Ng PC, Henikoff S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13): 3812–3814.
  • Niklasson L, Rasmussen P, Oskarsdottir S, Gillberg C. 2009. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil 30(4): 763–773.
  • Norton N, Li D, Rieder MJ, Siegfried JD, Rampersaud E, Zuchner S, Mangos S, Gonzalez-Quintana J, Wang L, McGee S, et al. 2011. Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 88(3): 273–282.
  • Oskarsdottir S, Vujic M, Fasth A. 2004. Incidence and prevalence of the 22q11 deletion syndrome: A population-based study in Western Sweden. Arch Dis Child 89(2): 148–151.
  • Ou Z, Berg JS, Yonath H, Enciso VB, Miller DT, Picker J, Lenzi T, Keegan CE, Sutton VR, Belmont J, et al. 2008. Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet Med 10(4): 267–277.
  • Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, Westphal KG, Olivier B, Sulzer D, Pavlidis P, et al. 2005. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 8(11): 1586–1594.
  • Paylor R, Glaser B, Mupo A, Ataliotis P, Spencer C, Sobotka A, Sparks C, Choi CH, Oghalai J, Curran S, et al. 2006. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103(20): 7729–7734.
  • Ramelli GP, Silacci C, Ferrarini A, Cattaneo C, Visconti P, Pescia G. 2008. Microduplication 22q11.2 in a child with autism spectrum disorder: Clinical and genetic study. Dev Med Child Neurol 50(12): 953–955.
    Direct Link:
  • Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 30(17): 3894–3900.
  • Schellenberg GD, Dawson G, Sung YJ, Estes A, Munson J, Rosenthal E, Rothstein J, Flodman P, Smith M, Coon H, et al. 2006. Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry 11(11): 1049–1060 979.
  • Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15(8): 1034–1050.
  • Stankiewicz P, Lupski JR. 2002. Genome architecture, rearrangements and genomic disorders. Trends Genet 18(2): 74–82.
  • Stankiewicz P, Lupski JR. 2010. Structural variation in the human genome and its role in disease. Annu Rev Med 61: 437–455.
  • State MW. 2010. The genetics of child psychiatric disorders: Focus on autism and Tourette syndrome. Neuron 68(2): 254–269.
  • Torres-Juan L, Rosell J, Morla M, Vidal-Pou C, Garcia-Algas F, de la Fuente MA, Juan M, Tubau A, Bachiller D, Bernues M, et al. 2007. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: A new susceptibility factor for mental retardation. Eur J Hum Genet 15(6): 658–663.
  • Tsuang MT, Faraone SV, Bingham S, Young K, Prabhudesai S, Haverstock SL, Mena F, Menon AS, Pepple J, Johnson J, et al. 2000. Department of Veterans Affairs Cooperative Studies Program genetic linkage study of schizophrenia: Ascertainment methods and sample description. Am J Med Genet 96(3): 342–347.
    Direct Link:
  • Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H. 2006. The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45(9): 1104–1113.
  • Wechsler D. 1992. Wechsler intelligence scale for children - third edition (WISC-III). San Antonio: The Psychological Corporation.
  • Wechsler D. 2002. Wechsler individual achievement test - second edition. San Antonio: The Psychological Corporation
  • Wiehahn GJ, Bosch GP, du Preez RR, Pretorius HW, Karayiorgou M, Roos JL. 2004. Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 129B(1): 20–22.
    Direct Link:
  • Williams NM, Glaser B, Norton N, Williams H, Pierce T, Moskvina V, Monks S, Del Favero J, Goossens D, Rujescu D, et al. 2008. Strong evidence that GNB1L is associated with schizophrenia. Hum Mol Genet 17(4): 555–566.
  • Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, et al. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362(9393): 1366–1373.
  • Yan W, Jacobsen LK, Krasnewich DM, Guan XY, Lenane MC, Paul SP, Dalwadi HN, Zhang H, Long RT, Kumra S, et al. 1998. Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired”. Am J Med Genet 81(1): 41–43.
    Direct Link:
  • Yobb TM, Somerville MJ, Willatt L, Firth HV, Harrison K, MacKenzie J, Gallo N, Morrow BE, Shaffer LG, Babcock M, et al. 2005. Microduplication and triplication of 22q11.2: A highly variable syndrome. Am J Hum Genet 76(5): 865–876.
  • Yu S, Cox K, Friend K, Smith S, Buchheim R, Bain S, Liebelt J, Thompson E, Bratkovic D. 2008. Familial 22q11.2 duplication: A three-generation family with a 3-Mb duplication and a familial 1.5-Mb duplication. Clin Genet 73(2): 160–164.
    Direct Link:
  • Zweier C, Sticht H, Aydin-Yaylagul I, Campbell CE, Rauch A. 2007. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 80(3): 510–517.
View Full Article with Supporting Information (HTML) Get PDF (662K)